These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biochemical correlates of cardiac hypertrophy. I. Experimental model; changes in heart weight, RNA content, and nuclear RNA polymerase activity. Nair KG; Cutilletta AF; Zak R; Koide T; Rabinowitz M Circ Res; 1968 Sep; 23(3):451-62. PubMed ID: 4234069 [No Abstract] [Full Text] [Related]
3. [Dynamics of nucleic acid and protein synthesis in the myocardium during compensatory hyperfunction and cardiac hypertrophy]. Meerson FZ; Alekhina GM; Aleksandrov PN; Bazardzhan AG Kardiologiia; 1967 May; 7(5):3-12. PubMed ID: 4238582 [No Abstract] [Full Text] [Related]
4. Accumulation of lipofuscin in the myocardium of senile guinea pigs: dissolution and removal of lipofuscin following dimethylaminoethyl p-chlorophenoxyacetate administration. An electron microscopic study. Spoerri PE; Glees P; El Ghazzawi E Mech Ageing Dev; 1974; 3(5-6):311-21. PubMed ID: 4618294 [No Abstract] [Full Text] [Related]
5. Determination of deoxyribonucleic acid content of heart muscle in experimental cardiac hypertrophy. Sasaki R; Morishita T; Yamagata S Tohoku J Exp Med; 1970 Jun; 101(2):153-9. PubMed ID: 4247667 [No Abstract] [Full Text] [Related]
6. DEOXYRIBONUCLEIC ACID CONTENT (FEULGEN PHOTOMETRY) AND DRY WEIGHT (INTERFERENCE MICROSCOPY) OF NORMAL AND HYPERTROPHIC HEART MUSCLE FIBERS. SANDRITTER W; SCOMAZZONI G Nature; 1964 Apr; 202():100-1. PubMed ID: 14166707 [No Abstract] [Full Text] [Related]
7. Myocardial metabolic changes in cardiac hypertrophy and heart failure. Fizelova A; Fizel A Recent Adv Stud Cardiac Struct Metab; 1972; 1():200-12. PubMed ID: 4283436 [No Abstract] [Full Text] [Related]
8. [Lipofuscin in cardiac myocytes of mice treated with oxamniquine]. Mello ML; Bertuzzo CS Rev Inst Med Trop Sao Paulo; 1984; 26(5):241-2. PubMed ID: 6533748 [No Abstract] [Full Text] [Related]
9. [Presence of lipofuscin masses in the myocardium of Torpedo m]. Aloj Totàro E Boll Soc Ital Biol Sper; 1981 Apr; 57(8):880-2. PubMed ID: 7272061 [TBL] [Abstract][Full Text] [Related]
10. [Comparative studies on lipofuscin content in the heart]. Stepień A; Buczyński E Patol Pol; 1972; 23(4):451-9. PubMed ID: 4640598 [No Abstract] [Full Text] [Related]
12. Electron microscopy of lipofuscin pigment stained by the Schmörl and Fontana techniques. Hendy R Histochemie; 1971; 26(4):311-8. PubMed ID: 4104824 [No Abstract] [Full Text] [Related]
13. Cardiac hypertrophy and heart failure: dynamics of changes in proteins and nucleic acids. Fizelova A; Fizel A J Mol Cell Cardiol; 1970 Dec; 1(4):389-402. PubMed ID: 4255340 [No Abstract] [Full Text] [Related]
14. Increased turnover of mitochondrial constituents in cardiac hypertrophy and acute hypoxia in the rat. Aschenbrenner V; Albin R; Zak R; Nair KG; Rabinowitz M Recent Adv Stud Cardiac Struct Metab; 1972; 1():178-85. PubMed ID: 4377823 [No Abstract] [Full Text] [Related]
16. Biochemical correlates of cardiac hypertrophy. 3. Changes in DNA content; the relative contributions of polyploidy and mitotic activity. Grove D; Nair KG; Zak R Circ Res; 1969 Oct; 25(4):463-71. PubMed ID: 4242254 [No Abstract] [Full Text] [Related]
17. [Lipofuscin accumulation, aging and vitality in a biological system]. Wiegel D; Brehme KH; Beier W Z Alternsforsch; 1972; 26(1):51-6 passim. PubMed ID: 4651464 [No Abstract] [Full Text] [Related]